| 
Citations
 | 
   web
Jahan, N., Lee, J. M., Shah, K., & Wakimoto, H. (2017). Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. Int J Cancer, 141(8), 1671–1681.
toggle visibility
Yan, H., Romero-Lopez, M., Benitez, L. I., Di, K., Frieboes, H. B., Hughes, C. C. W., et al. (2017). 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. Cancer Res, 77(15), 4171–4184.
toggle visibility
Thomas, A. A., Abrey, L. E., Terziev, R., Raizer, J., Martinez, N. L., Forsyth, P., et al. (2017). Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma. Neuro Oncol, 19(10), 1380–1390.
toggle visibility
Oliva, C. R., Zhang, W., Langford, C., Suto, M. J., & Griguer, C. E. (2017). Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit. Oncotarget, 8(23), 37568–37583.
toggle visibility
Kim, M. Y., Park, S. - J., Shim, J. W., Song, Y. J., Yang, K., Park, S. - J., et al. (2017). Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cells. Oncol Lett, 13(3), 1767–1774.
toggle visibility